Clinical Application of Serum Tumor Associated Material (TAM) from Non-small Cell Lung Cancer Patients

Abstract

Objective: To explore the associations of serum tumor associated material (TAM) with other common tumor markers like carcinoembryonic antigen (CEA), carbohydrate antigen 125 (CA125), carbohydrate antigen19-9 (CA19-9) and its clinical application in non-small cell lung cancer (NSCLC) patients. Methods: A total of 87 patients were enrolled into this study, all with histologically or cytologically confirmed NSCLC. With the method of chemical colorimetry, the level of TAM was determined and compared, while chemiluminescence was used to measure the levels of common tumor markers. Results: The level of TAM decreased after chemotherapy compared with before chemotherapy when CT or MRI scans showed disease control. Furthermore, it increased when disease progessed and there was no statistically significant difference in monitoring of TAM and common tumor markers (P>0.05). Conclusions: Detecting TAM in NSCLC patients has a higher sensitivity and specificity, so it can be used as an indicator for clinical monitoring of lung cancer chemotherapy.

Clinical Study on Safety of Cantharidin Sodium and Shenmai Injection Combined with Chemotherapy in Treating Patients with Breast Cancer Postoperatively

“…Statistically significant difference was set at p<0.05. We have enough experience in conducting medical researches, and have published some results elsewhere (Gong et al, 2012;Li et al, 2012;Yu et al, 2012;Deng et al, 2013;Liu et al, 2013;Wu et al, 2013;Lu et al, 2013;Shen et al, 2013;Yan et al, 2013).…”

Analysis of CEA Expression and EGFR Mutation Status in Non-small Cell Lung Cancers

“…A Japanese study investigated the relationship between EGFR mutation status and serum CEA expression level at different stages of NSCLC; it was found that EGFR mutations in lung cancer were related to the serum CEA expression level in recurrent tumors, but not the preoperative serum CEA expression level (Shoji et al, 2007). A domestic study regarding the relationship between CEA expression level in NSCLC surgical specimens and EGFR mutation status demonstrated that NSCLC patients with abnormally elevated CEA protein expression were prone to suffer from EGFR mutations, and this correlation was statistically significant (Kappers et al, 2010;Li et al, 2012). Wang et al found that within a certain range, the EGFR gene mutation rate would increase with increasing preoperative serum CEA expression level (Wang et al, 2012).…”

Inhibition of Tumor Growth in Vitro by a Combination of Extracts from Rosa Roxburghii Tratt and Fagopyrum Cymosum

“…P<0.05 was considered statistically significant. The study group has enough experience in conducting medical researches, and has published some results elsewhere (Huang et al, 2004;Zhou et al, 2009;Jiang et al, 2010;Yan et al, 2010;Gao et al, 2011;Huang et al, 2011;Yan et al, 2011;Zhang et al, 2011;Gong et al, 2012;Li et al, 2012;Yu et al, 2012).…”